← Evidence map

ArticleJournal of food allergy2024

Omalizumab in food allergy: Risks and benefits.

S Shahzad Mustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40771704